Presented by
IVBM Event Coverage
Pharmacy Innovations That Improve Care Quality, Cut Costs: A Q&A With Jose Guzman Garcia, PharmD, MHA, BCCCP
Jose Guzman Garcia, PharmD, MHA, BCCCP, discusses key pharmacy initiatives at UC Davis Health.
AI Can Help Community and Academic Oncology Practices: Tina Bhatnagar, DO
Bhavana (Tina) Bhatnagar, DO, discusses the transformative role of AI in enhancing patient care at West Virginia University Cancer Institute.
Invest in Human Capital to Improve Breast Cancer Care Delays: Adam Brufsky, MD, PhD
Delays in breast cancer diagnosis and treatment highlight the need for improved human capital investment in health care systems, explains Adam Brufsky, MD, PhD.
Team-Based Cancer Care Vital in the Community: Danielle Roman, PharmD, BCOP
Danielle Roman, PharmD, BCOP, explains why a collaborative, team-based approach is essential to solving resource challenges in community cancer care.
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
Experts at a roundtable in Boston, Massachusetts, on November 3, 2025, discussed improving early Alzheimer disease diagnosis, addressing workforce and equity gaps, and expanding access to new disease-modifying therapies.
Digital Innovation and New Drugs Converge to Transform CRM Care
Academic and clinical experts convened in New Haven, Connecticut, on October 30, 2025, to discuss the potential of coordinated care and prevention to manage cardio-renal-metabolic (CRM) disease.
Transforming Population Health for Diabetes and Kidney Disease via Systems of Excellence
Clinicians and health system leaders met in Cleveland, Ohio, on October 23, 2025, to share improvements to value-based care in diabetes and chronic kidney disease.
Expanding Precision Care for Alzheimer Disease, Multiple Sclerosis
Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis.
Innovative Approaches in Academic Neurology Workflows
Experts at an Institute for Value-Based Medicine event held October 14, 2025, in Aurora, Colorado, explored advances in neurology care, cross-specialty collaboration, and strategies to improve access and therapy.
Technology Drives Innovation, Accessibility When Treating Chronic Kidney Disease
Experts met in Park City, Utah, on October 7, 2025, to discuss how new technologies can help address chronic kidney disease.
Redesigning Trials for Real-World Patient Complexity: A Q&A With Prerna Mewawalla, MD
Prerna Mewawalla, MD, discusses innovative strategies to enhance cancer care access, reduce clinician burden, and improve clinical trial diversity in real-world settings.
Managing Cardio-Renal-Metabolic Diseases Requires Multifactorial Approach
Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.
Precision Medicine Advances Highlight Ongoing Equity Challenges: Tina Bhatnagar, DO
Despite the impact of targeted treatment in oncology, much work remains to bring these therapeutics to all patients, says Bhavana (Tina) Bhatnagar, DO.
Setting the Stage for Collaborative Care to Address CKM Syndrome
Payer and health system leaders convened in Pittsburgh, Pennsylvania, on September 9, 2025, to discuss the interconnected health conditions of cardiovascular-kidney-metabolic (CKM) syndrome.
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
Kavita Nair, PhD, FAAN, shares how new therapies and ongoing clinical trials are reshaping the future of neurological care and offering new hope to patients.
Barriers and Breakthroughs Ahead for Personalizing Adjuvant Therapy: Michael Hassett, MD
Michael Hassett, MD, explains the evolving landscape of HER2-positive breast cancer treatment and the role of CDK inhibition in personalized therapy strategies.
Postpandemic Breast Cancer Screening Rates Explained: Adam Brufsky, MD, PhD
Adam Brufsky, MD, PhD, addresses how the COVID-19 pandemic affected breast cancer screening rates across Pittsburgh.
How Academic Medical Centers Address Neurological Care: Kavita Nair, PhD, FAAN
Kavita Nair, PhD, FAAN, discusses academic medical centers' unique role in diagnosing and managing neurodegenerative diseases.
How Pharmacists Expand Rural Cancer Care Access: Jasmine Eugene, PharmD
Jasmine Eugene, PharmD, explains how pharmacists practicing at the top of their license improve rural oncology access and ease physician workload.
Telemedicine’s Role in Bridging Cancer Care Gaps: Clark Alsfeld, MD
Clark Alsfeld, MD, discusses how telemedicine, pharmacists, and evolving policies help overcome financial and geographic barriers in oncology care.
Pharmacy Is Essential to Navigating Breast Cancer Treatment: Danielle Roman, PharmD, BCOP
Danielle Roman, PharmD, BCOP, discusses the challenges of accessing genomic test results and managing prior authorization in patient care for breast cancer.
Diet, Lifestyle Come Into Focus for Managing Multiple Sclerosis: Rebecca Spain, MD
Diet and wellness impact multiple sclerosis management, enhancing quality of life and reducing fatigue through lifestyle changes and holistic approaches.
Expanding CAR T-Cell Access With Broader Criteria and Real-World Data: Clark Alsfeld, MD
Broader eligibility, real-world data, and community partnerships are expanding access to CAR T-cell therapy.
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
Explore how the Veteran Affairs (VA) MS Centers of Excellence enhance veteran care through a hub-and-spoke model, telehealth, and groundbreaking research.
Improving Cancer Care Equity in Louisiana: Melanie Sheen, MD
Ochsner MD Anderson expands cancer care access in Louisiana through community partnerships, technology, and strong patient-physician relationships.
How Alzheimer Treatment Delivery Must Evolve: Darla Chapman, DNP
Nurse practitioners play an essential role in diagnosing, treating, and supporting individuals living with Alzheimer disease.
Improving Clinical Trial Diversity by Building Trust: Melanie Sheen, MD
Melanie Sheen, MD, describes efforts to boost diverse clinical trial enrollment through trust, community partnerships, and equitable patient engagement.
Innovative Oncology Care Strategies Addressing Social Determinants of Health: Lingling Du, MD
Oncology care advances target social determinants of health through AI, patient education, and community engagement.
How MS Treatment Strategies Are Evolving: Rebecca Spain, MD
Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.
Early Alzheimer Diagnosis Key to Better Outcomes: Darla Chapman, DNP
Darla Chapman, DNP, ARNP, University of Washington, speaks on the evolution of Alzheimer diagnosis, emphasizing early detection and innovative biomarkers.
